IV 
113TH CONGRESS 
1ST SESSION 
H. RES. 133 
Commending the progress made by anti-tuberculosis programs. 
IN THE HOUSE OF REPRESENTATIVES 
MARCH 21, 2013 
Mr. ENGEL (for himself, Mr. YOUNG of Alaska, Mr. GENE GREEN of Texas, 
Ms. SCHAKOWSKY, Mr. LEVIN, Mr. SMITH of Washington, Mr. HONDA, 
Mrs. CAROLYN B. MALONEY of New York, Ms. LEE of California, Mr. 
PAYNE, Ms. ROYBAL-ALLARD, Mr. HASTINGS of Florida, and Ms. LOF-
GREN) submitted the following resolution; which was referred to the Com-
mittee on Foreign Affairs, and in addition to the Committee on Energy 
and Commerce, for a period to be subsequently determined by the Speak-
er, in each case for consideration of such provisions as fall within the ju-
risdiction of the committee concerned 
RESOLUTION 
Commending the progress made by anti-tuberculosis 
programs. 
Whereas tuberculosis (TB) is the second leading fatal global 
infectious disease behind HIV/AIDS, claiming 3 people 
each minute and 1,400,000 lives each year; 
Whereas the global TB pandemic and the spread of drug-re-
sistant TB present a persistent public health threat to 
the United States, and cases of drug-resistant TB in the 
United States have increased; 
Whereas TB treatment is long and arduous, ranging from 6 
months to 2 years, and requires multiple medications, 
VerDate Mar 15 2010 
16:12 Mar 22, 2013
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR133.IH
HR133
srobinson on DSK4SPTVN1PROD with BILLS
•HRES 133 IH 
and the side effects of treatment for drug-resistant TB 
can include acute pain and hearing loss; 
Whereas periodic TB drug shortages have occurred in many 
countries, including the United States, because of insuffi-
cient production by manufacturers and supply chain 
problems; 
Whereas the first new drug to treat TB in the last 40 years 
was approved by the FDA in January 2013; 
Whereas diabetic patients are 3 times more likely to develop 
TB compared to those without diabetes; 
Whereas TB is the leading killer of people with HIV/AIDS 
in the developing world, more than 1,000 people infected 
with HIV die every day from tuberculosis, and there is 
also a critical need for new TB drugs that can safely be 
taken concurrently with antiretroviral therapy for HIV; 
Whereas health care workers are 2 to 3 times more likely to 
contract TB than the general population, yet protection 
from infection is inadequate in many countries; 
Whereas TB is an under-recognized problem in children and 
current pediatric treatments and diagnostics are inad-
equate; 
Whereas the disease can have devastating long-term health 
effects including deafness, blindness, and paralysis, even 
after cure; 
Whereas TB is the third leading killer of adult women, and 
the stigma associated with TB disproportionately affects 
women, often causing delays in seeking care and inter-
fering with treatment adherence; 
VerDate Mar 15 2010 
16:12 Mar 22, 2013
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR133.IH
HR133
srobinson on DSK4SPTVN1PROD with BILLS
•HRES 133 IH 
Whereas breadwinners who become ill with TB are often too 
sick to work for weeks or months, which can lead to fi-
nancial catastrophe for their families; 
Whereas the Institute of Medicine (IOM) found that the re-
surgence of TB in the United States between 1985 and 
1992 was caused by cuts in TB control funding and the 
spread of HIV/AIDS; 
Whereas the numbers of TB cases in the United States con-
tinue to decline; 
Whereas drug-resistant TB that appears resistant to all 
medication has been found in India and South Africa, 
and the United States has had more than 28 cases of Ex-
tensively Drug-Resistant TB (XDR–TB) over the last 
decade, with 6 cases in 2011 alone; 
Whereas there are indications that drugs sold over the 
counter in pharmacies in several countries with poor na-
tional drug control systems may be fake or sub-standard; 
Whereas African-Americans are 8 times more likely to have 
TB than Caucasians, and significant disparities exist 
among other minorities in the United States, including 
Native Americans, Asian-Americans, and Hispanic-Amer-
icans; 
Whereas although drugs, diagnostics, and vaccines for TB 
exist, many are antiquated and are increasingly inad-
equate for controlling the global epidemic; 
Whereas the TB vaccine, BCG, provides some protection to 
children, but it has little or no efficacy in adults; 
Whereas progress has been made in vaccine research, with 
more than a dozen vaccine candidates in clinical trials; 
VerDate Mar 15 2010 
17:58 Mar 22, 2013
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6300
E:\BILLS\HR133.IH
HR133
srobinson on DSK4SPTVN1PROD with BILLS
•HRES 133 IH 
Whereas enactment of the Tom Lantos and Henry J. Hyde 
United States Global Leadership Against HIV/AIDS, Tu-
berculosis, and Malaria Reauthorization Act of 2008 and 
the Comprehensive TB Elimination Act provided a his-
toric United States commitment to the global eradication 
of TB, leading to the successful treatment of 4,500,000 
new TB patients and 90,000 new multi-drug-resistant 
cases by 2013, while providing additional treatment 
through coordinated multilateral efforts; 
Whereas an estimated 20,000,000 people are alive today as 
a direct result of TB programs; 
Whereas a new, United States-developed diagnostic tech-
nology, called Xpert, is revolutionizing the TB response; 
Whereas TB-related deaths among people living with HIV in 
Africa have declined by 28 percent since 2004; 
Whereas the United States Agency for International Develop-
ment (USAID) provides financial and technical assist-
ance to nearly 32 highly burdened TB countries, supports 
the development of new diagnostic and treatment tools, 
and is authorized to support research to develop new vac-
cines to combat TB; 
Whereas the Centers for Disease Control and Prevention 
(CDC), working in partnership with States and terri-
tories of the United States, directs the national TB elimi-
nation program and essential national TB surveillance, 
technical assistance, and prevention activities and sup-
ports the development of new diagnostic, treatment, and 
prevention tools to combat TB; 
Whereas the United States President’s Emergency Plan for 
AIDS Relief (PEPFAR) supports programs to integrate 
the prevention, diagnosis, and treatment of TB into HIV 
VerDate Mar 15 2010 
16:12 Mar 22, 2013
Jkt 029200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6300
E:\BILLS\HR133.IH
HR133
srobinson on DSK4SPTVN1PROD with BILLS
•HRES 133 IH 
services, as well as programs to integrate HIV preven-
tion, testing, care, and treatment into TB programs; 
Whereas the National Institutes of Health, through its many 
institutes and centers, plays the leading role in basic and 
clinical research into the identification, treatment, and 
prevention of TB; 
Whereas the Global Fund to Fight AIDS, Tuberculosis, and 
Malaria provides 90 percent of all international financing 
for TB programs worldwide and has supported the detec-
tion and treatment of 9,700,000 cases of TB; and 
Whereas March 24, 2013, is World Tuberculosis Day, com-
memorating the date in 1882 when Dr. Robert Koch an-
nounced his discovery of Mycobacterium tuberculosis, the 
bacteria that causes tuberculosis: Now, therefore, be it 
Resolved, That the House of Representatives— 
(1) supports the goals of World Tuberculosis 
Day to raise awareness about tuberculosis; 
(2) commends the progress made by United 
States-led anti-tuberculosis programs; and 
(3) reaffirms its commitment to global tuber-
culosis control made through the Tom Lantos and 
Henry J. Hyde United States Global Leadership 
Against HIV/AIDS, Tuberculosis, and Malaria Re-
authorization Act of 2008. 
Æ 
VerDate Mar 15 2010 
16:12 Mar 22, 2013
Jkt 029200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\HR133.IH
HR133
srobinson on DSK4SPTVN1PROD with BILLS